Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Solek P et al. | 2018 | - | 50/60 Hz, magnetic field | - |
| Salinas-Asensio MM et al. | 2019 | - | magnetic field, 50/60 Hz, low frequency, signals/pulses, co-exposure, therapeutic/medical device | - |
| Yadamani S et al. | 2020 | - | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Xu A et al. | 2020 | - | magnetic field, 50/60 Hz, low frequency | - |
| Denaro V et al. | 2011 | intact cell/cell culture | low frequency, signals/pulses, 50/60 Hz, magnetic field | 0.4 mT |
| An GZ et al. | 2015 | intact cell/cell culture, BALB/3T3 cells (embryonal mouse fibroblasts) | magnetic field, 50/60 Hz | 2.3 mT |
| Marcantonio P et al. | 2010 | intact cell/cell culture, BE(2)C cells (human neuroblastoma cells) | magnetic field, low frequency, 50/60 Hz, co-exposure | 1 mT |
| Tian F et al. | 2002 | intact cell/cell culture, CHO-K1 (Chinese hamster ovary K1) cells (Ku80-proficient) und xrs5 cells (Ku80-defizient; radiation sensitive mutant isolated from CHO-K1 cells) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Reipert BM et al. | 1996 | intact cell/cell culture, FDCP-mix(A4) cell line (mouse bone marrow cells) | magnetic field, static magnetic field, 50/60 Hz, shielding/field deprivation | 0.2–65 µT |
| Eremenko T et al. | 1997 | intact cell/cell culture, Friend erythroleukemia cell line (clone 745 A) | magnetic field, geomagnetic field, 50/60 Hz, shielding/field deprivation | 0.0025 nT–70 µT |
| Solek P et al. | 2017 | intact cell/cell culture, GC-1 cells (murine spermatogonia cell line); GC-2 cells (murine spermatocyte cell line) | magnetic field, 50/60 Hz, signals/pulses | 2.5–8 mT |
| Liu Y et al. | 2016 | intact cell/cell culture, GC-2 cells (murine spermatocyte-derived cell line) | magnetic field, 50/60 Hz | 1–3 mT |
| Cios A et al. | 2021 | intact cell/cell culture, HEK293 (kidney cells), 786-O, 769-P, and Caki1 (clear cell renal carcinoma cell lines) | magnetic field, 50/60 Hz | 4.5 mT |
| Cridland NA et al. | 1999 | intact cell/cell culture, HF-19 cells (human fetal lung fibroblasts) | magnetic field, 50/60 Hz | 20 µT–20 mT |
| Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 60 µT |
| Wolf FI et al. | 2005 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells); WI-38 (embryonic human lung fibroblasts); Rat-1 (rat fibroblasts) | magnetic field, 50/60 Hz | 500 µT–1 mT |
| Schimmelpfeng J | 1997 | intact cell/cell culture, HL-60 (human promyelocytic leukemia cells) | magnetic field, 50/60 Hz, co-exposure | 2 mT |
| Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | 60 µT |
| Huang CY et al. | 2014 | intact cell/cell culture, HaCaT cells (human keratinocytes) partially transfected with CHK2 siRNA | magnetic field, 50/60 Hz, shielding/field deprivation | 1.5 mT |
| Harris PA et al. | 2002 | intact cell/cell culture, HeLa S3 (human cervical carcinoma cell line) | magnetic field, 50/60 Hz | 2 mT |
| Mannerling AC et al. | 2010 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, low frequency, 50/60 Hz | 0.025–0.1 mT |
| Brisdelli F et al. | 2014 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, co-exposure | 0.01–2 mT |
| Jin H et al. | 2015 | intact cell/cell culture, L123 cells (human lung epithelial cells) | magnetic field, 50/60 Hz, co-exposure | 1–2 mT |
| Markkanen A et al. | 2008 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz, co-exposure | 100–300 µT |
| Ding GR et al. | 2001 | intact cell/cell culture, MCF-7 (human breast cancer cell line) | magnetic field, 50/60 Hz, co-exposure | 5 mT |
| Ramazi S et al. | 2023 | intact cell/cell culture, MCF-7 (human breast cancer cell line) and HFF cells (human foreskin fibroblast cells) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | - |
| Dees C et al. | 1996 | intact cell/cell culture, MCF-7 and T-47D cell lines (human breast cancer cell lines) | magnetic field, 50/60 Hz, co-exposure | 1.2–900 µT |
| Martinez MA et al. | 2016 | intact cell/cell culture, NB69 cells (human neuroblastoma cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Guo H et al. | 2004 | intact cell/cell culture, SNU cells (human gastric adenocarcinoma cell line) | magnetic field, 50/60 Hz | 97 mT |
| Schimmelpfeng J et al. | 1993 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) | electric field, magnetic field, 50/60 Hz | 2 mT |
| Schimmelpfeng J et al. | 1997 | intact cell/cell culture, SV40-swiss-3T3 cells (mouse fibroblast cell line) and HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 2 mT |
| Su L et al. | 2017 | intact cell/cell culture, U251 and A127 (human glioblastoma cell lines), SH-SY5Y (human neuroblastoma cell line), rat astrocytes, rat microglia, primary cortical neurons (of rat) | magnetic field, low frequency, 50/60 Hz | 2 mT |
| Akbarnejad Z et al. | 2017 | intact cell/cell culture, U87 (human glioblastoma cell line) | magnetic field, signals/pulses, 50/60 Hz | 5–10 mT |
| Saalman E et al. | 1991 | intact cell/cell culture, V79 (Chinese hamster fibroblast cells) | magnetic field, 50/60 Hz | 30 µT |
| Koh EK et al. | 2008 | intact cell/cell culture, different human prostate carcinoma cell lines (DU145, LNCaP, PC3) | magnetic field, 50/60 Hz, power transmission line | 0.2–2.5 mT |
| Ma Q et al. | 2014 | intact cell/cell culture, embryonic neural stem cells (mouse/BALB/c) | magnetic field, 50/60 Hz | 0.5–2 mT |
| Sul AR et al. | 2006 | intact cell/cell culture, hFOB 1.19 (human fetal osteoblasts), T/G HA-VSMC (human aortic vascular smooth muscle cells), RPMI 7666 (human B lymphoblasts) and HCN-2 (human cortical neuronal cells) | magnetic field, 50/60 Hz | 2 mT |
| Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
| Lange S et al. | 2004 | intact cell/cell culture, human amniotic fluid cells (AFC) | magnetic field, 50/60 Hz, co-exposure, also other exposures without EMF | 1 mT |
| Richard D et al. | 2002 | intact cell/cell culture, human diploid amniotic fluid cells | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Lange S et al. | 2002 | intact cell/cell culture, human diploid amniotic fluid cells | magnetic field, 50/60 Hz | 1 mT |
| Huang CY et al. | 2014 | intact cell/cell culture, human epidermal keratinocytes (derived from neonatal foreskin) and HaCaT cells (human keratinocytes) | magnetic field, 50/60 Hz | 1.5 mT |
| Zhang M et al. | 2013 | intact cell/cell culture, human epidermal stem cells | magnetic field, low frequency, 50/60 Hz | 5 mT |
| Koziorowska A et al. | 2017 | intact cell/cell culture, human neonatal fibroblast BJ | 50/60 Hz, magnetic field, low frequency, signals/pulses | 2.5 mT |
| Giorgi G et al. | 2014 | intact cell/cell culture, human neuroblastoma cell line (BE(2)C) | magnetic field, 50/60 Hz, co-exposure | 1 mT |
| Luukkonen J et al. | 2017 | intact cell/cell culture, human neuroblastoma cell line (SH-SY5Y) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
| Antonopoulos A et al. | 1995 | intact cell/cell culture, human peripheral blood | magnetic field, 50/60 Hz | 5 mT |
| Rosenthal M et al. | 1989 | intact cell/cell culture, human peripheral blood | magnetic field, 50/60 Hz | 0.1–7.5 mT |
| Khalil AM et al. | 1991 | intact cell/cell culture, human peripheral blood | magnetic field, signals/pulses, 50/60 Hz | 1.05 mT |
| Cohen MM et al. | 1986 | intact cell/cell culture, human peripheral blood and 5 lymphoblastoid cell lines (normal - GM 1525, ataxia telangiectasia - GM 1525, xeroderma pigmentosum - D 7031, Bloom syndrome - GM 4408, Fanconi anemia - HSC 230) | electric field, magnetic field, 50/60 Hz | 0.1–0.2 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
